| Product NDC: | 63323-339 |
| Proprietary Name: | Vancomycin Hydrochloride |
| Non Proprietary Name: | VANCOMYCIN HYDROCHLORIDE |
| Active Ingredient(s): | 250 mg/1 & nbsp; VANCOMYCIN HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-339 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065453 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120618 |
| Package NDC: | 63323-339-20 |
| Package Description: | 2 BLISTER PACK in 1 CARTON (63323-339-20) > 10 CAPSULE in 1 BLISTER PACK |
| NDC Code | 63323-339-20 |
| Proprietary Name | Vancomycin Hydrochloride |
| Package Description | 2 BLISTER PACK in 1 CARTON (63323-339-20) > 10 CAPSULE in 1 BLISTER PACK |
| Product NDC | 63323-339 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | VANCOMYCIN HYDROCHLORIDE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120618 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | VANCOMYCIN HYDROCHLORIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Glycopeptide Antibacterial [EPC],Glycopeptides [Chemical/Ingredient] |